Internal Medicine

Ischemic Heart Disease

The Oxygen-Starved Heart

Amos Asamoah
October 2025
5 min read
Cardiovascular Disease

Today we're tackling ischemic heart disease (IHD), the leading cause of death worldwide. IHD occurs when there's an imbalance between myocardial oxygen supply and demand, most commonly due to coronary artery disease. I'll guide you through the spectrum of IHD; from stable angina to acute coronary syndromes. Understanding this condition is crucial because timely recognition and treatment can save lives. Let's dive into the world of coronary circulation and what happens when it's compromised!

🩺 Definition and Spectrum of IHD

Ischemic heart disease encompasses a range of conditions caused by impaired blood flow to the myocardium. The clinical presentation varies based on the severity and chronicity of ischemia.

Chronic Coronary Syndromes

  • Stable angina: Predictable chest pain with exertion
  • Silent ischemia: Asymptomatic ECG changes
  • Variant (Prinzmetal) angina: Coronary vasospasm

Acute Coronary Syndromes

  • Unstable angina: Pain at rest, worsening pattern
  • NSTEMI: Non-ST elevation MI
  • STEMI: ST elevation MI
Condition Pathophysiology ECG Changes Cardiac Enzymes
Stable Angina Fixed stenosis, demand ischemia ST depression during pain Normal
Unstable Angina Plaque rupture, thrombus ST depression/T-wave inversion Normal
NSTEMI Partial occlusion, necrosis ST depression/T-wave inversion Elevated
STEMI Complete occlusion, transmural necrosis ST elevation, Q waves Elevated
Clinical Pearl: Remember the "Rule of 100s" for coronary artery stenosis: >70% stenosis typically causes symptoms with exertion, >90% stenosis can cause symptoms at rest.

🔄 Pathophysiology of Atherosclerosis

The fundamental process underlying most IHD is atherosclerosis - a chronic inflammatory disease of the arterial wall that develops over decades through complex interactions between lipids, inflammatory cells, and vascular elements.

Initiation Phase

  • Endothelial injury/dysfunction
  • LDL accumulation in intima
  • Monocyte recruitment and differentiation
  • Foam cell formation

Progression Phase

  • Smooth muscle cell migration
  • Extracellular matrix deposition
  • Plaque growth and remodeling
  • Necrotic core formation

Complication Phase

  • Plaque rupture/erosion
  • Thrombus formation
  • Vasospasm
  • Acute occlusion
Tutor Tip: Think of atherosclerosis as a "response to injury" process where the artery wall tries to heal itself but ends up creating the problem.

👨‍⚕️ Clinical Presentation

The hallmark of IHD is chest pain, but presentations can vary dramatically from classic angina to atypical symptoms, especially in women, diabetics, and elderly patients.

Classic Angina Features

Character

  • Location: Substernal, retrosternal
  • Radiation: Jaw, neck, arms (especially left)
  • Quality: Pressure, squeezing, heaviness
  • Severity: Typically 3-10/10

Pattern

  • Duration: 2-10 minutes (stable), longer in ACS
  • Precipitants: Exertion, emotion, cold, meals
  • Relievers: Rest, nitroglycerin
  • Associated: Dyspnea, nausea, diaphoresis

Atypical Presentations

Population Atypical Symptoms Clinical Clues
Women Fatigue, shortness of breath, indigestion Often without classic chest pain
Diabetics Silent ischemia, dyspnea only Autonomic neuropathy masks pain
Elderly Confusion, weakness, syncope Multiple comorbidities complicate picture
Post-CABG Atypical pain patterns Denervated myocardium post-surgery
ACS Red Flags: Chest pain at rest, prolonged pain (>20 min), pain with hemodynamic instability, syncope, or new heart failure symptoms require immediate evaluation for acute coronary syndrome.

🔍 Diagnosis and Risk Stratification

Diagnosis of IHD involves a stepwise approach starting with clinical assessment, followed by non-invasive testing, and culminating in invasive angiography when indicated.

Diagnostic Approach

Test Indication Key Findings Limitations
Resting ECG All patients with chest pain ST changes, Q waves, arrhythmias Often normal between episodes
Stress ECG Intermediate probability, stable symptoms Exercise-induced ST depression Lower sensitivity in women, LBBB
Stress Echo Better localization of ischemia Wall motion abnormalities Operator dependent
Nuclear Imaging Uninterpretable ECG, prior revascularization Perfusion defects Radiation exposure, cost
Coronary CTA Low-intermediate probability, atypical symptoms Anatomical assessment of stenosis Calcium artifacts, radiation
Invasive Angio High probability, ACS, positive non-invasive tests Direct visualization of coronaries Invasive, contrast, radiation
Important: Always calculate pre-test probability using validated scores (Diamond-Forrester, CAD Consortium) to guide appropriate testing strategy and avoid unnecessary procedures.

💊 Management Strategies

Management of IHD focuses on symptom relief, prevention of disease progression, and reduction of cardiovascular events through lifestyle modification, pharmacotherapy, and revascularization.

Medical Therapy

Symptom Relief

  • Nitrates: Short and long-acting
  • Beta-blockers: Reduce oxygen demand
  • Calcium channel blockers: Vasodilation
  • Ranolazine: Late sodium current inhibition

Event Prevention

  • Antiplatelets: Aspirin, P2Y12 inhibitors
  • Statins: LDL reduction, plaque stabilization
  • ACE inhibitors/ARBs: Vascular protection
  • Beta-blockers: Post-MI, reduced mortality

Revascularization Options

Procedure Indications Advantages Limitations
PCI 1-2 vessel disease, ACS Minimally invasive, quick recovery Restenosis, stent thrombosis
CABG Left main, multivessel disease, diabetes Complete revascularization, durability Invasive, longer recovery
Treatment Goal: For stable CAD, medical therapy is often equivalent to PCI for mortality reduction. Revascularization is primarily for symptom relief in refractory cases.

⚠️ Acute Coronary Syndrome Management

ACS represents a medical emergency requiring rapid diagnosis and immediate intervention to limit myocardial damage and prevent complications.

Initial Management

  • MONA: Morphine, Oxygen, Nitrates, Aspirin
  • Dual antiplatelets: Aspirin + P2Y12 inhibitor
  • Anticoagulation: Heparin/enoxaparin
  • Beta-blockers: If no contraindications

Reperfusion Strategy

  • Primary PCI: Gold standard for STEMI
  • Fibrinolytics: If PCI not available within 120 min
  • Early invasive: For high-risk NSTEMI/UA
  • Ischemia-guided: For low-risk NSTEMI/UA
Clinical Insight: Door-to-balloon time for STEMI should be <90 minutes, and door-to-needle time for fibrinolysis should be <30 minutes to maximize myocardial salvage.

🧠 Key Takeaways

  • IHD results from imbalance between myocardial oxygen supply and demand
  • Atherosclerosis is the primary underlying pathology
  • Spectrum ranges from stable angina to acute coronary syndromes
  • Clinical presentation varies - classic angina vs. atypical symptoms
  • Diagnosis involves risk stratification and appropriate testing
  • Medical therapy focuses on symptoms and event prevention
  • Revascularization (PCI/CABG) is primarily for symptom relief in stable CAD
  • ACS requires immediate reperfusion to limit myocardial damage

🧭 Conclusion

We've navigated the complex landscape of ischemic heart disease, student—from the slow progression of atherosclerosis to the sudden drama of acute coronary syndromes. Remember that IHD management requires a comprehensive approach addressing both the immediate concerns and long-term risk factors. I encourage you to master the recognition of ACS and understand when urgent intervention is needed. Excellent progress! Next, we'll explore arrhythmias and how electrical disturbances affect the heart.

Time is muscle in acute coronary syndromes—rapid recognition and treatment can save both myocardium and lives.

← Previous Topic: Heart Failure Next Topic: Arrhythmias →